Home The Wall Street Journal: NovoCure falls below reduced IPO price in market debut
 

Keywords :   


The Wall Street Journal: NovoCure falls below reduced IPO price in market debut

2015-10-03 22:12:05| Biotech - Topix.net

Shares in oncology company NovoCure Ltd. fell sharply in their trading debut Friday, the latest example of investors' waning appetite for biotechnology shares and for initial public offerings. shares opened at $20.16, below their initial public offering price of $22.

Tags: price street market journal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 BUG ! TOO !
23.11BTS 10 FESTA ARMY JUNGKOOK
23.11 SAO 2015
23.1178580g
23.112
23.1170
23.11 BOX
23.11
More »